Scientists discover how new drug kills roundworms

NewsGuard 100/100 Score

PLoS Neglected Tropical Diseases study found how a new drug developed by scientists in China effectively kills roundworms – "a parasite that lurks in the intestines and which affects nearly two billion people in tropical countries," Reuters reports. "Roundworms are particularly harmful to children and pregnant women," Reuters writes.

 "Apart from causing malnutrition and developmental problems in children, the parasite can cause blindness if it enters the eye. Repeated infections can also bring about swelling of the organs and the central nervous system."

The findings of the study may help offer an alternative to the current roundworm treatment albendazole – a drug that roundworms have started to develop resistance to, according to Reuters (Lyn, 8/11). As part of the study, researchers analyzed the way that the drug tribendimidine kills the roundworm parasite, according to a University of California at San Diego/EurekAlert press release. Tribendimidine "has not yet been approved for human use" but has shown success at killing "some roundworm parasites, such as hookworms" in clinical trials in Africa and China (8/10).

The results led the scientists to conclude tribendimidine "could be effectively used in areas where parasites are likely to or have already developed a resistance to albendazole," ANI/Sindh Today reports (8/11).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Blood protein could be a potential biomarker for delayed concussion recovery in children